Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads by Date Must reads for theWeek ending October 13, 2019 Risk of Psoriasis Increased With Chronic Rhinosinusitis, Patients With Psoriasis Show Increased CV Risk, Obesity and Dyslipidemia in Patients With Psoriasis, More must reads Must reads for theWeek ending September 1, 2019 Patients With Psoriasis Have Distinct Structural and Functional Fecal Microbiota, Improving Adherence to Topical Drugs in Patients With Psoriasis, Developing a Utility Scoring Algorithm for the PASI, In Psoriasis, Risankizumab Outperforms Adalimumab, More must readsMust reads for theWeek ending August 4, 2019 Effects of Biologic Therapies on Peripheral Blood Eosinophils in Psoriasis, Narrowband UVB Phototherapy in Psoriasis and Atopic Dermatitis, Prevalence of Obesity in Patients With Psoriasis, More must readsMust reads for theWeek ending July 7, 2019 Lp-PLA2 as a Predictor of Comorbidities in Severe Psoriasis, Proinflammatory and Anti-Inflammatory Cytokine Profiles in Psoriasis, Prevalence of Onychomycosis in Patients with Psoriasis, More must readsMust reads for theWeek ending June 2, 2019 Dysbiosis of Skin Microbiota in Patients with Psoriasis, Monocytes/Macrophages in IL-23 Skin Infections, Drug Survival Rates in Psoriasis, More must readsPages« first 1 2
